Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer

by Channing J Paller, Emmanuel S Antonarakis
Published 2011-03-01

Corrigendum

by Channing J Paller, Emmanuel S Antonarakis
Published 2011-03-01

Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer

by Albert Jang, Oliver Sartor, Pedro C. Barata, Channing J. Paller
Published 2020-11-01

PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy

by Wallace Jones, Kelly Griffiths, Pedro C. Barata, Channing J. Paller
Published 2020-05-01

Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials

by Gina Nauman, Javaughn Corey Gray, Rose Parkinson, Mark Levine, Channing J. Paller
Published 2018-07-01

Vas deferens infiltration by prostate cancer on prostate-specific membrane antigen-targeted18F-DCFPyL positron emission tomography/computed tomography: A unique visual pattern

by Yafu Yin, Channing J Paller, Martin G Pomper, Kenneth J Pienta, Michael A Gorin, Steven P Rowe
Published 2019-01-01

Val16A SOD2 Polymorphism Promotes Epithelial–Mesenchymal Transition Antagonized by Muscadine Grape Skin Extract in Prostate Cancer Cells

by Janae D. Sweeney, Marija Debeljak, Stacy Riel, Ana Cecilia Millena, James R. Eshleman, Channing J. Paller, Valerie Odero-Marah
Published 2021-02-01

Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials

by Channing J. Paller, Erich P. Huang, Thomas Luechtefeld, Holly A. Massett, Christopher C. Williams, Jinxiu Zhao, Amy E. Gravell, Tami Tamashiro, Steven A. Reeves, Gary L. Rosner, Michael A. Carducci, Lawrence Rubinstein, S. Percy Ivy
Published 2019-06-01

Muscadine grape skin extract inhibits prostate cancer cells by inducing cell-cycle arrest, and decreasing migration through heat shock protein 40

by Diane N. Ignacio, Kimberly D. Mason, Ezra C. Hackett-Morton, Christopher Albanese, Lymor Ringer, William D. Wagner, Paul C. Wang, Michael A. Carducci, Sushant K. Kachhap, Channing J. Paller, Janet Mendonca, Leo Li-Ying Chan, Bo Lin, Diane K. Hartle, Jeffrey E. Green, Collis A. Brown, Tamaro S. Hudson
Published 2019-01-01

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

by Hamza Hasan, Matthew P. Deek, Ryan Phillips, Robert F. Hobbs, Reem Malek, Noura Radwan, Ana P. Kiess, Shirl Dipasquale, James Huang, Terry Caldwell, Jessica Leitzel, Danielle Wendler, Hao Wang, Elizabeth Thompson, Jonathan Powell, Sara Dudley, Curtiland Deville, Stephen C. Greco, Daniel Y. Song, Theodore L. DeWeese, Michael A. Gorin, Steven P. Rowe, Sam Denmeade, Mark Markowski, Emmanuel S. Antonarakis, Michael A. Carducci, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Channing J. Paller, Phuoc T. Tran
Published 2020-06-01